Phathom Pharmaceuticals, Inc. (PHAT)

NASDAQ: PHAT · IEX Real-Time Price · USD
11.05
+0.55 (5.24%)
At close: Mar 27, 2024, 4:00 PM
10.97
-0.08 (-0.72%)
Pre-market: Mar 28, 2024, 4:26 AM EDT

Phathom Pharmaceuticals Market Cap

Phathom Pharmaceuticals has a market cap or net worth of $608.75 million as of March 28, 2024. Its market cap has increased by 125.55% in one year.

Market Cap
608.75M
Enterprise Value
663.34M
1-Year Change
125.55%
Ranking
Category
Stock Price
$11.05

Market Cap Chart

Since October 25, 2019, Phathom Pharmaceuticals's market cap has decreased from $636.70M to $608.75M, a decrease of -4.39%. That is a compound annual growth rate of -1.01%.

History

DateMarket Cap% Change
Mar 26, 2024614.00M0.47%
Mar 25, 2024611.10M-5.17%
Mar 22, 2024644.40M20.29%
Mar 21, 2024535.70M0.45%
Mar 20, 2024533.30M5.79%
Mar 19, 2024504.10M4.11%
Mar 18, 2024484.20M-2.48%
Mar 15, 2024496.50M9.26%
Mar 14, 2024454.40M-2.86%
Mar 13, 2024467.80M-2.09%
Mar 12, 2024477.80M-1.08%
Mar 11, 2024483.00M-6.99%
Mar 8, 2024519.30M-2.31%
Mar 7, 2024531.60M-4.58%
Mar 6, 2024557.10M-2.01%
Mar 5, 2024568.50M-3.50%
Mar 4, 2024589.10M-3.74%
Mar 1, 2024612.00M-0.10%
Feb 29, 2024612.60M-0.75%
Feb 28, 2024617.20M6.21%
Feb 27, 2024581.10M2.41%
Feb 26, 2024567.40M-6.51%
Feb 23, 2024606.90M1.25%
Feb 22, 2024599.40M2.55%
Feb 21, 2024584.50M0.38%
View and export this data all the way back to 2019. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Novavax 673.17M
Nurix Therapeutics 666.92M
OPKO Health 666.12M
Savara 665.87M
Fulgent Genetics 659.44M
Acelyrin 656.07M
Tevogen Bio Holdings 653.52M
Mineralys Therapeutics 641.24M
Market Cap Rankings